Comparison of the Efficacy of Piperacillin/Tazobactam and Meropenem, with or without Intravenous Immunoglobulin, as Second-Line Therapy for Febrile Neutropenia: A Prospective, Randomized Study

• Main Authors: Hirozumi Sano (Author), Ryoji Kobayashi (Author), Satoru Matsushima (Author), Daiki Hori (Author), Masato Yanagi (Author), Koya Kodama (Author), Daisuke Suzuki (Author), Kunihiko Kobayashi (Author)
• Format: Book
• Published: The Korean Society of Pediatric Hematology-Oncology, 2021-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background : : Febrile neutropenia (FN) remains an important complication in pediatric cancer patients. The present study compared the efficacy of meropenem (MEPM) and piperacillin/tazobactam (PIPC/TAZ) with or without intravenous immunoglobulin (IVIG) as second-line therapy for FN in pediatric pati...